Neonatal cytokines and coagulation factors in children with cerebral palsy

Annals of Neurology

Volumn 44, Issue 4, 1998, Pages 665-675

  Nelson, Karin B ^a,d   Dambrosia, James M ^a   Grether, Judith K ^b   Phillips, Terry M ^c  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b California Birth Defects Monitoring Program   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5 LEIDEN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CEREBRAL PALSY; CHEMOLUMINESCENCE; CHILD; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MALE; MICROANALYSIS; PRIORITY JOURNAL;

AUTOANTIBODIES; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; CEREBRAL PALSY; CHEMOKINES; CHILD, PRESCHOOL; CYTOKINES; FEASIBILITY STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; MALE; REFERENCE VALUES;

EID: 0031783968     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440413     Document Type: Article

References (79)

1. Newacheck PW, Taylor WR. Childhood chronic illness: prevalence, severity, and impact. Am J Public Health 1992;82:364-371
2. Ireys HT, Anderson GF, Shaffer TJ, Neff JM. Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid program, fiscal year 1993. Pediatrics 1997; 100:197-204
3. Hagberg B, Hagberg G. Olow I, von Wendt L. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-90. Acta Paediatr 1996;85: 954-960
4. Topp M, Uldall P, Langhoff-Roos J. Trend in cerebral palsy birth prevalence in eastern Denmark: birth-year period 1979-86. Paediatr Perinat Epidemiol 1997;11:451-460
5. Cummins SK, Nelson KB, Grether JK, Velie EM. Cerebral palsy in four northern California counties, births 1983 through 1985. J Pediatr 1993;123:230-237
6. Phillips TM. Measurement of recombinant interferon levels by high performance immunoaffinity chromatography in body fluids of cancer patients on interferon therapy. Biomed Chromatogr 1992;6:287-290
7. Phillips TM. Immunoaffinity measurement of recombinant granulocyte colony stimulating factor in patients with chemotherapy-induced neutropenia. J Chromatogr B Biomed Appl 1994;662:307-313
8. Phillips TM, Kimmel PL. High performance capillary electrophoretic analysis of inflammatory citokines in human biopsies. J Chromatogr B Biomed Appl 1994;656:259-266
9. Garrick MD, Dembure P, Guthrie R. Sickle-cell anemia and other hemoglobinopathies. Procedures and strategy for screening employing spots of blood on filter paper as specimens. N Engl J Med 1973;288:1265-1268
10. Cassol SA, Read S, Weniger BG, et al. Dried blood spots collected on filter paper: an international resource for the diagnosis and genetic characterization of human immunodeficiency virus type-1. Mem Inst Oswaldo Cruz 1996;91:351-358
11. Loffredo CA, Ewing CK. Use of stored newborn blood spots in research on birth defects: variation in retrieval rates by type of defect and infant characteristics. Am J Med Genet 1997;69: 85-88
12. Nelson KB, Ellenberg JH. Predictors of low and very low birth weight and the relation of these to cerebral palsy. JAMA 1985; 254:1473-1479
13. Cooke RWI. Cerebral palsy in very low birthweight infants. Arch Dis Child 1990;65:201-206
14. Murphy DJ, Sellers S, MacKenzie IZ, et al. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet 1995;346:1449-1454
15. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birthweight. JAMA 1997;278:207-211
16. Reith J, Jorgensen HS, Pedersen PM, et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996;347:422-425
17. Grau AJ. Infection, inflammation, and cerebrovascular ischemia. Neurology 1997;49(Suppl):S47-S51
18. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979
19. Tashiro H, Shimokawa H, Yamamoto K, et al. Altered plasma levels of cytokines in patients with ischemic heart disease. Coron Artery Dis 1997;8:143-147
20. Rothwell NJ. The role of cytokines in neurodegeneration. In: Rothwell NJ, ed. Cytokines in the nervous system. New York: Chapman and Hall, 1996:145-162
21. Salafia CM, Parke AL. Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome. Rheum Dis Clin North Am 1997;23:85-97
22. Bertina RM. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 1997;43:1678-1683
23. von Scheven E, Athreya BH, Rose CD, et al. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediarr 1996;129:339-345
24. Thorarensen O, Ryan S, Hunter J, Younkin DP. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis. Ann Neurol 1997;42:372-375
25. de Klerk OL, de Vries TW, Sinnige LGF. An unusual cause of neonatal seizures in a newborn infant. Pediatrics 1997;100:e8
26. Grether JK, Cummins SK, Nelson KB. The California cerebral palsy project. Paediatr Perinat Epidemiol 1992;6:339-351
27. Phillips TM. Measurement of total and bioactive interleukin-2 in tissue samples by immunoaffinity-receptor affinity chromatography. Biomed Chromatogr 1997;11:200-204
28. Phillips TM, Krum JM. Recycling immunoaffinity chromatography for multiple analyte analysis in biological samples. J Chromatogr B Biomed Appl (In press)
29. Jacobs DS, Demott WR, Grady HJ, et al. Laboratory test handbook. 4th ed. Cleveland, OH: Lex-Comp, 1994
30. Wallach J. Interpretation of diagnostic tests. 6th ed. Boston: Little, Brown, 1996:3-30
31. Tukey JW. Exploratory data analysis. Reading, MA: AddisonWesley, 1972
32. Chambers JM, Cleveland WS, Kleiner B, Tukey PA. Graphical methods for data analysis. Boston: Duxbury Press, 1983
33. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Belmont, CA: Wadsworth International, 1984
34. Yoon BH, Kim CJ, Romero R, et al. Experimentally induced intrauterine infection causes brain white matter lesions in rabbits. Am J Obstet Gynecol 1997;177:797-802
35. Deguchi K, Mizuguchi M, Takashima S. Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia. Pediatr Neurol 1996;14:13-16
36. Farwell AP. Sick euthyroid syndrome. J Intensive Care Med 1997;12:249-260
37. Roitt I. Essential immunology. 8th ed. London: Blackwell Scientific, 1994:174
38. Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG. The role of cytokines in gestation. Crit Rev Immunol 1994;14:239-292
39. Merrill JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 1992;14:1-10
40. Mehler MF, Kessler JA. Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci 1997; 20:357-365
41. Toulmond S, Parnet P, Linthorst ACE. When cytokines get on your nerves: cytokine networks and CNS pathologies. Trends Neurosci 1996;19:409-410
42. Hallenbeck JM, Dutka AJ, Kochanek PM, et al. Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. Stroke 1988;19:863-869
43. Lincinio J, Kling MA, Hauser P. Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes. Semin Oncol 1998;25(Suppl 1):30-38
44. Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996;19:331-338
45. Volpe JJ. Neurologic outcome of prematurity. Arch Neurol 1998;55:297-300
46. Pintavorn P, Ballermann BJ. TGF-beta and the endothelium during immune injury. Kidney Int 1997;51:1401-1412
47. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 1997;349:1391-1392
48. Hunt BJ, Jurd KM. Relation between endothelial-cell activation and infection, inflammation, and infarction. Lancet 1997;350: 293 (Abstract)
49. Mehler MF, Rozental R, Dougherty M, et al. Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 1993;362:62-65
50. Kim SU. Cytokine networks in human CNS identified in cultured human neurons, astrocytes, and microglia. Ann Neurol 1997;42:424 (Abstract)
51. Nencini P, Baruffi MC, Abbate R, et al. Lupus anticoagulant and cardiolipin antibodies in young adults with cerebral ischemia. Stroke 1992;23:189-193
52. Nowak-Gottl U, Koch HG, Aschka I, et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 1996;92:992-998
53. Israels SJ, Seshia SS. Childhood stroke associated with protein C or S deficiency. J Pediatr 1987;111:562-564
54. Dusscr A, Bover-Neumann C, Wolf M. Temporary protein C deficiency associated with cerebral arterial thrombosis in childhood. J Pediatr 1988;113:849-851
55. Rumi V, Angelini L, Scaioli V, et al. Primary antiphospholipid syndrome and neurologic events. Pediatr Neurol 1993;9:473-475
56. Parke A, Maier D, Hakim C, et al. Subclinical autoimmune disease and recurrent spontaneous abortion. J Rheumatol 1986; 13:1178-1180
57. Cowchock S. Autoantibodies and pregnancy loss. N Engl J Med 1997;337:197-198
58. Dizon-Townson DS, Meline L, Nelson LM, et al. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997;177:402-405
59. Gould RJ, Black K, Pavlakis SG. Neonatal cerebral arterial thrombosis: protein C deficiency. J Child Neurol 1996;11: 250-252
60. Takanashi J, Sugita K, Miyazato S, et al. Antiphospholipid antibody syndrome in childhood strokes. Pediatr Neurol 1995;13: 323-326
61. Silver RK, MacGregor SN, Pasternak JF, Neely SE. Fetal stroke associated with elevated maternal anticardiolipin antibodies. Obstet Gynecol 1992;80:497-499
62. Miossec P. Cytokine-induced autoimmune disorders. Drug Saf 1997;17:93-104
63. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol 1995;26:80-85
64. Burke CJ, Tannenberg AE, Payton DJ. Ischaemic cerebral injury, intrauterine growth retardation, and placental infarction. Dev Med Child Neurol 1997;39:726-730
65. Kraus FT. Cerebral palsy and thrombi in placental vessels of the fetus: insights from litigation. Hum Pathol 1997;28:246-248
66. Hooper WC, Phillips DJ, Evatt BL. TNF-alpha suppresses IL-6 upregulation of protein S in HepG-2 hepatoma cells. Thromb Res 1996;81:315-326
67. Esmon CT, Fukudome K, Mather T, et al. Inflammation: the protein C pathway. Fibrinolysis Proteolysis 1997:11:(Suppl 1): 143-148
68. Espana F, Zuazu I, Vicente V, et al. Quantification of circulating activated protein C in human plasma by immunoassays -enzyme levels are proportional to total protein C levels. Thromb Haemost 1996;75:56-61
69. Macko RF, Killewich LA, Fernandez JA, et al. Brain-specific protein C activation during carotid artery occlusion in humans. Ann Neurol 1997;42:438 (Abstract)
70. Gil A, Gonzalez A, Re-Dal R, et al. Detection of antibodies against hepatitis A in blood spots dried on filter paper. Is this a reliable method for epidemiological studies. Epidemiol Infect 1997;118:189-191
71. Parker SP, Taylor MB, Ades AE, et al. Use of dried blood spots for the detection and confirmation of HTLV-1 specific antibodies for epidemiological purposes. J Clin Pathol 1995;48: 904-907
72. Parry JV, Mortimer PP, Nicoll AG. Performance assessment of neonatal blood spot testing for HIV antibody. Commun Dis Rep CDR Rev 1992;2:R128-130
73. Biggar RJ, Miley W, Miotti P, et al. Blood collection on filtet paper: a practical approach to sample collection for studies of perinatal HIV transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:368-373
74. O'Broin SD. Influence of hematocrit on quantitative analysis of "blood spots" on filter paper. Clin Chem 1993;39:1354-1355
75. O'Broin SD, Kelleher BP, Gunter E. Evaluation of factots influencing precision in the analysis of samples taken from blood spots on filter paper. Clin Lab Haematol 1995;17:185-188
76. Phillips TM. High-performance immunoaffinity chromatography. In: Giddings JC, Grushka E, Brown PR, eds. Advanced chromatography, vol 29. New York: Marcel Dekker, 1989:133-173
77. Miller LC, Isa S, LoPreste G, et al. Neonatal interleukin-1beta, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production. J Pediatt 1990;117:961-965
78. Phillips TM. Measurement of bioactive neuropeptides using a Chromatographic immunosensor cattridge. Biomed Chromatogr 1996;10:331-336
79. Phillips TM, Kennedy LM, De Fabo EC. Microdialysis-immunoaffinity capillary electrophoresis studies on neuropeptide-induced lymphocyte secretion. J Chromatogr B Biomed Appl 1997;697:101-109